# The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)

> **NCT02629510** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 268 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Cancer

## Interventions

- **DRUG:** Tachosil

## Key facts

- **NCT ID:** NCT02629510
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02629510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02629510, "The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02629510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*